Lorem ipsum dolor

Lorem ipsum dolor

Lorem ipsum dolor

• Lorem ipsum dolor sit amet, consectetuer adipiscing elit. • Pellentesque egestas iaculis tellus.

• Nunc id quam ut nunc placerat mollis.

• Mauris euismod feugiat mi.

Pellentesque egestas

0

5

10

15

20

25

HaCat A549

Control

F-Ara

F-Arad

Presentation Title

Presenter and Affiliation

Welcome and Introductions

Lorem Ipsum

Break

Lorem Ipsum

Break

Lorem Ipsum

Lunch

Lorem Ipsum

Lorem Ipsum

Lorem Ipsum

Lorem Ipsum

Contents

Bullet Slide

• Lorem ipsum dolor sit amet, consectetuer adipiscing elit.

• Pellentesque egestas iaculis tellus.

• Nunc id quam ut nunc placerat mollis.

• Mauris euismod feugiat mi.

Figure Slide

EATEAI EAD

Exercise Title

• Lorem ipsum dolor sit amet, consectetuer adipiscing elit.

• Pellentesque egestas iaculis tellus.

• Nunc id quam ut nunc placerat mollis.

• Mauris euismod feugiat mi.

Review Title

Open / General

Closed / Specific

Chapter Heading

Sub Chapter Heading

For internal use only Issue 1: aug 2002

H next

Bonefos SymposiumChaired by:

Professor John A Kanis

World Health Organisation Collaborating Centre for Metabolic Bone DiseasesUniversity of Sheffield, UK

Sponsor: Leiras, subsidiary of Schering AG

12 April 2002Arktikum CentreRovaniemi, Lapland

For internal use only

Issue 1aug 2002

A major player in long-term osteoprotection

Bonefos Global Strategy

BONEFOS

PROSTATECANCER

BREASTCANCER

MULTIPLEMYELOMA

Clinical efficacy and tolerability of oral Bonefos in long-term use

back

next

email

For internal use only

Issue 1aug 2002

Enduring Materials

Bonefos symposium highlight report: New Insights into Bonefos Therapy

Timeline: to be available by (To be determined)Cost: (To be determined) per copyOrdering: (To be determined)

back

email